SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic
INTC 34.11-2.8%2:06 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonny McWilliams who wrote (25617)3/17/2000 4:28:00 AM
From: Brian Malloy  Read Replies (1) of 27012
 
VVUS back in the MEWS <ggg>

The Night Watch: What Better Stock for the Night
Watch -- Vivus Rocks the House
By Eric Gillin
Staff Reporter
3/16/00 8:04 PM ET

Someone get Bob Dole on the horn!

Right before the end of trading, investors got all hot and bothered about Vivus
(VVUS:Nasdaq - news - boards), a California-based manufacturer of
impotence fighting products. At 3 p.m. EST, the company announced that it
received a patent on a new cream that will help keep men like Dole out of
politics and in the bedroom. It works on the same chemistry as Viagra, using
phosphodiesterase inhibitors to keep men happy.

After the news hit the street, Vivus stock rose quickly,
ending with a gain of 2 3/32 to 8 23/32 on 5.9 million shares,
with the majority of that volume occurring in the final 45
minutes. That momentum carried over into the night session.
Vivus continued to get it on, gaining 5/16 to 8 15/16 on 1.2
million shares on Island ECN. Meanwhile, across town on
Instinet, Vivus was the second-most active issue with a gain of 11/64 to 8
29/32 on 127,000 shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext